Frontiers in Psychiatry · 2022 · 26 citations · 44 references
MedicineNeurologyNeuroscienceDementiaMemoryNeurogeneticsCognitive AssessmentCognitive DeclineCognitive DisordersCognitive GeneticsCognitive ImpairmentCognitive SymptomsApoe GeneticsApolipoprotein E Genotype RiskCognitive ComplaintsCognitive Impairment AssociationsCognitive Impairment EvaluationCognitive PhenotypesCognitive Status AssessmentLong-term Cognitive Impairment
Introduction Few studies have objectively evaluated cognitive deficits after the acute phase of COVID-19 disease. Moreover, the role of apolipoprotein E (APOE) genotypes in cognitive decline in patients with COVID-19 has not been evaluated yet. Methods This cross-sectional study was conducted in confirmed cases of COVID-19 patients with neurological symptoms that persisted for more than 3 months from the onset. We determined APOE genotypes. Results The final sample consisted of 141 patients. The most frequent APOE genotype was E3/E3 ( N = 95; 67.3%). In total, 93 patients (65.9%) had memory impairment symptoms as the main complaint, objectively confirmed through screening tests in 25 patients (17.7%). Patients with cognitive impairment had a lower frequency of anosmia than the normal and subjective cognitive decline (SCD) groups ( p = 0.005). In addition, depression was recurrent in the cognitive impairment group and the SCD group ( p = 0.046). Cognitive impairment was significantly more frequent in hospitalized patients and those with a lower education level. Cognitive status was not associated with APOE genotypes. Discussion Hospitalized patients had more severe infection with a greater possibility of systemic complications, greater inflammatory response, and prolonged hospitalization, which could impact cognitive performance. Cognitive impairment in patients with COVID-19 does not necessarily involve specific APOE polymorphisms. However, psychiatric disorders may also be responsible for cognitive complaints. Cognitive complaints are frequent in patients with COVID-19, even after the acute phase of the disease and in mild cases. Hospitalized participants and depressed patients may have a higher risk of cognitive impairment. APOE genotypes or haplotypes may not significantly play a role in COVID-19 cognitive impairment.
44
Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 86.9K citations
Clinical Characteristics of Coronavirus Disease 2019 in China
Wei‐jie Guan, Zhengyi Ni, Yu Hu et al. · New England Journal of Medicine · 2020 · 31.2K citations · Full text
Veterinary Medicine, Infectious Diseases, Internal Medicine +10
Older Adults' Reasons for Using Technology while Aging in Place
Sebastiaan Theodorus Michaël Peek, Katrien Luijkx, M. D. Rijnaard et al. · Gerontology · 2015 · 19.7K citations · Full text